2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Prostatic Neoplasms
6
Thyroid Nodule
5
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Thyroid Neoplasms
3
Thyroid Cancer, Papillary
3
Uterine Cervical Dysplasia
2
Sarcoma
2
Prostatic Hyperplasia
2
Papillomavirus Infections
2
Melanoma
2
Liver Neoplasms
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder, Neurogenic
1
Urinary Bladder Neoplasms
1
Spinal Dysraphism
1
Spinal Cord Compression
1
Recurrence
1
Precancerous Conditions
1
Papillary Thyroid Microcarcinoma
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Unknown Primary
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Hypospadias
1
Interventions
Biopsy
12
Peripheral Blood Stem Cell Transplantation
9
Cyclophosphamide
9
fludarabine phosphate
8
Whole-Body Irradiation
8
Polymerase Chain Reaction
7
Tacrolimus
6
Mycophenolic Acid
6
Gene Expression Profiling
6
Colposcopy
6
Busulfan
6
Microarray Analysis
5
Immunohistochemistry
5
Epoetin Alfa
5
Celecoxib
5
Aminolevulinic Acid
5
Sulindac
4
Selenium
4
Methotrexate
4
Melphalan
4
Cyclosporine
4
Cetuximab
4
Antilymphocyte Serum
4
Vaginal Smears
3
Imiquimod
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Etoposide
3
Eflornithine
3
Darbepoetin alfa
3
Comparative Genomic Hybridization
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precancerous Conditions
×
Transurethral Resection of Prostate
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled